X

Sign up for Equitymaster's free daily newsletter, The 5 Minute WrapUp and get access to our latest Multibagger guide (2018 Edition) on picking money-making stocks.

This is an entirely free service. No payments are to be made.


Download Now Subscribe to our free daily e-letter, The 5 Minute WrapUp and get this complimentary report.
We hate spam as much as you do. Check out our Privacy Policy and Terms Of Use.
Compare SUVEN LIFE with Wockhardt - Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

SUVEN LIFE vs WOCKHARDT LTD. - Comparison Results

WOCKHARDT LTD. 
   Change

Wockhardt is one of the leading domestic pharmaceutical companies with strong presence in the lifestyle segment and a growing focus on biotechnology. While the company made a string of acquisitions in the past namely 'Esparma GmbH' in Germany, 'Pinew... More

DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    SUVEN LIFE WOCKHARDT LTD. SUVEN LIFE/
WOCKHARDT LTD.
 
P/E (TTM) x 19.4 -22.2 - View Chart
P/BV x 4.2 2.3 188.5% View Chart
Dividend Yield % 0.5 0.0 31,396.2%  

Financials

 SUVEN LIFE   WOCKHARDT LTD.
EQUITY SHARE DATA
    SUVEN LIFE
Mar-18
WOCKHARDT LTD.
Mar-18
SUVEN LIFE/
WOCKHARDT LTD.
5-Yr Chart
Click to enlarge
High Rs2511,012 24.8%   
Low Rs155532 29.2%   
Sales per share (Unadj.) Rs49.1355.9 13.8%  
Earnings per share (Unadj.) Rs9.7-60.3 -16.1%  
Cash flow per share (Unadj.) Rs11.4-46.8 -24.4%  
Dividends per share (Unadj.) Rs1.500.01 15,000.0%  
Dividend yield (eoy) %0.70 57,054.0%  
Book value per share (Unadj.) Rs60.3257.8 23.4%  
Shares outstanding (eoy) m127.28110.63 115.1%   
Bonus/Rights/Conversions ---  
Price / Sales ratio x4.12.2 190.5%   
Avg P/E ratio x20.9-12.8 -163.1%  
P/CF ratio (eoy) x17.8-16.5 -107.9%  
Price / Book Value ratio x3.43.0 112.4%  
Dividend payout %15.40 -93,044.3%   
Avg Mkt Cap Rs m25,82585,379 30.2%   
No. of employees `0001.16.3 17.1%   
Total wages/salary Rs m6139,371 6.5%   
Avg. sales/employee Rs Th5,832.66,295.0 92.7%   
Avg. wages/employee Rs Th571.51,498.3 38.1%   
Avg. net profit/employee Rs Th1,153.8-1,066.3 -108.2%   
INCOME DATA
Net Sales Rs m6,25339,369 15.9%  
Other income Rs m2331,202 19.4%   
Total revenues Rs m6,48540,571 16.0%   
Gross profit Rs m1,98218 10,829.5%  
Depreciation Rs m2131,495 14.3%   
Interest Rs m462,555 1.8%   
Profit before tax Rs m1,955-2,830 -69.1%   
Minority Interest Rs m00-   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m0-3,582 0.0%   
Tax Rs m718257 279.5%   
Profit after tax Rs m1,237-6,669 -18.5%  
Gross profit margin %31.70 68,187.1%  
Effective tax rate %36.7-9.1 -404.5%   
Net profit margin %19.8-16.9 -116.8%  
BALANCE SHEET DATA
Current assets Rs m5,62233,796 16.6%   
Current liabilities Rs m1,16826,917 4.3%   
Net working cap to sales %71.217.5 407.7%  
Current ratio x4.81.3 383.5%  
Inventory Days Days8179 102.6%  
Debtors Days Days3689 40.3%  
Net fixed assets Rs m3,32539,664 8.4%   
Share capital Rs m127553 23.0%   
"Free" reserves Rs m7,54727,968 27.0%   
Net worth Rs m7,67428,522 26.9%   
Long term debt Rs m1421,731 0.1%   
Total assets Rs m9,13581,620 11.2%  
Interest coverage x43.2-0.1 -40,203.9%   
Debt to equity ratio x00.8 0.2%  
Sales to assets ratio x0.70.5 141.9%   
Return on assets %14.0-5.0 -278.7%  
Return on equity %16.1-23.4 -68.9%  
Return on capital %26.0-7.7 -339.2%  
Exports to sales %00-   
Imports to sales %00-   
Exports (fob) Rs mNANA-   
Imports (cif) Rs mNANA-   
Fx inflow Rs m5,0669,807 51.7%   
Fx outflow Rs m2,0011,789 111.9%   
Net fx Rs m3,0658,019 38.2%   
CASH FLOW
From Operations Rs m699684 102.2%  
From Investments Rs m-66,302 -0.1%  
From Financial Activity Rs m-577-7,695 7.5%  
Net Cashflow Rs m116-664 -17.5%  

Share Holding

Indian Promoters % 63.4 74.5 85.1%  
Foreign collaborators % 0.0 0.0 -  
Indian inst/Mut Fund % 0.0 2.3 -  
FIIs % 0.0 7.7 -  
ADR/GDR % 0.0 0.1 -  
Free float % 36.5 15.4 237.0%  
Shareholders   37,287 67,757 55.0%  
Pledged promoter(s) holding % 0.0 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare SUVEN LIFE With:   ORCHID PHARMA LTD  WYETH LTD  ABBOTT INDIA  UNICHEM LAB  CIPLA  

Compare SUVEN LIFE With:   ACTAVIS (US)  ADCOCK INGRAM (S. Africa)  MYLAN (US)  TEVA PHARMA (Israel)  



Today's Market

Indian Indices End Marginally Lower; FMCG & IT Stocks Witness Losses(Closing)

After opening the day on a positive note today, Indian share markets witnessed losses thereafter and ended their trading session marginally lower.

Related Views on News

SUVEN LIFE Surges by 5%; BSE HEALTHCARE Index Up 1.3% (Market Updates)

Sep 26, 2018 | Updated on Sep 26, 2018

SUVEN LIFE share price has surged by 5% and its current market price is Rs 289. The BSE HEALTHCARE is up by 1.3%. The top gainers in the BSE HEALTHCARE Index is SUVEN LIFE (up 5.3%). The top losers are PIRAMAL ENTERPRISES (down 0.2%) and FORTIS HEALTHCARE (down 0.5%).

SUVEN LIFE 2017-18 Annual Report Analysis (Annual Result Update)

Aug 14, 2018 | Updated on Aug 14, 2018

Here's an analysis of the annual report of SUVEN LIFE for 2017-18. It includes a full income statement, balance sheet and cash flow analysis of SUVEN LIFE. Also includes updates on the valuation of SUVEN LIFE.

Aster DM Healthcare (IPO)

Feb 10, 2018

Should you subscribe to the IPO of Aster DM Healthcare Ltd?

Dr Reddy's: Milestone Payment Drives Sales (Quarterly Results Update - Detailed)

Feb 9, 2018

US business was hit by pricing pressure although there was growth sequentially led by new product launches.

Lupin: US market Declines Due to Higher Base Effect of FY17 (Quarterly Results Update - Detailed)

Feb 9, 2018

Price erosion in generic US drugs continues but seems to be bottoming out.

More Views on News

Most Popular

My First Pharma Stock Recommendation!(The 5 Minute Wrapup)

Sep 21, 2018

This company has not only created a niche in the pharma space, it has done so profitably.

Oh Yes! This is the Best Trading Opportunity in Two Decades(Profit Hunter)

Sep 21, 2018

Getting ready to buy stocks once this correction is over? This private sector bank should be on a profit hunter's radar.

Outperformance of Strong Established Brands in the Indian Stock market(Chart Of The Day)

Sep 14, 2018

Strong Well established Indian Brands have comfortably outperformed the index in the decade post the global financial crisis.

How IL&FS Rating Downgrade Will Impact Your Mutual Funds...(Outside View)

Sep 17, 2018

PersonalFN explains the impact of IL&FS rating downgrade on mutual funds.

How To Identify Sachin Tendulkars And Rahul Dravids Of Tomorrow For Your Mutual Fund Portfolio(Outside View)

Sep 19, 2018

PersonalFN explains how to pick 'undiscovered' or lesser-known mutual funds that are capable of generating big gains for you.

More

Small Investments
BIG Returns

Zero To Millions Guide 2018
Get our special report, Zero To Millions
(2018 Edition) Now!
We will never sell or rent your email id.
Please read our Terms

SUVEN LIFE SHARE PRICE


Sep 26, 2018 (Close)

TRACK SUVEN LIFE

  • Track your investment in SUVEN LIFE with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

SUVEN LIFE 8-QTR ANALYSIS

COMPARE SUVEN LIFE WITH

MARKET STATS